Eaton Vance Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.21M | Buy |
|
|||||
|
2022
Q2 | $5.04M | Sell |
|
|||||
|
2022
Q1 | $6.23M | Buy |
|
|||||
|
2021
Q4 | $1.59M | Sell |
|
|||||
|
2021
Q3 | $1.34M | Sell |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2021
Q1 | $1.36M | Sell |
|
|||||
|
2020
Q4 | $1.58M | Buy |
|
|||||
|
2020
Q3 | $1.33M | Sell |
|
|||||
|
2020
Q2 | $11.5M | Sell |
|
|||||
|
2020
Q1 | $8.71M | Buy |
|
|||||
|
2019
Q4 | $8.71M | Sell |
|
|||||
|
2019
Q3 | $7.11M | Sell |
|
|||||
|
2019
Q2 | $9.04M | Sell |
|
|||||
|
2019
Q1 | $11.2M | Sell |
|
|||||
|
2018
Q4 | $12.9M | Sell |
|
|||||
|
2018
Q3 | $14.8M | Sell |
|
|||||
|
2018
Q2 | $16.2M | Sell |
|
|||||
|
2018
Q1 | $30.6M | Sell |
|
|||||
|
2017
Q4 | $36.7M | Sell |
|
|||||
|
2017
Q3 | $44.9M | Buy |
|
|||||
|
2017
Q2 | $43.6M | Sell |
|
|||||
|
2017
Q1 | $48.8M | Sell |
|
|||||
|
2016
Q4 | $47M | Buy |
|
|||||
|
2016
Q3 | $29.9M | Sell |
|
|||||
|
2016
Q2 | $32.3M | Buy |
|
|||||
|
2016
Q1 | $4.13M | Buy |
|
|||||
|
2015
Q4 | $5.2M | Sell |
|
|||||
|
2015
Q3 | $5.31M | Buy |
|
|||||
|
2015
Q2 | $1.92M | Hold |
|
|||||
|
2015
Q1 | $1.75M | Buy |
|